PHARMACEUTICAL STUDIES OF ATENOLOL BRANDS: INTERCHANGEABILITY BETWEEN ATENOLOL (100 MG) TABLETS BRANDS MARKETED IN LIBYA
AbstractHypertension is the most widely distributed cardiovascular diseases in Libyan regions.Â Atenolol is one of most used Î²-blockers in Libya as the first line in treatment of hypertension.Â Therefore, In Libya there are several companies interested to import and distribute many Atenolol brands. The objective of this study was to evaluate the quality of five commercial Atenolol products available on the Libyan market. We carried out a survey of all Atenolol tablet products and assessed their quality. To assess quality, all productsof Atenolol such as: Atenolol tablets, ActavisUnited Kingdom, TotamolÂ tablets WOCKHARDT , United Kingdom, Atenolol NormonÂ Spain,Â Â Â Â Â Â Â Â Â Â Â Atenolol Film Coated tablets, BRISTOL, United Kingdom and HypotenÂ tablets, HIKMA Ammanâ€“Jordanwere subjected for the survey includes ten community and hospital pharmacies and volunteers.Â Our survey was including : Atenolol drug order , Pharmaceutical company sales, Atenolol drug cost, Atenolol drug prescription andÂ Atenolol drugPurchase.Based on our testing procedure, the data of our survey 80-90%, 40-60% and 40-50% of Atenolol tablets, Actavis, Atenolol Film Coated tablets and TotamolÂ tablets respectively are more requested and desired in Libyan drug market.Â Also, our data revealed 80% and 90% of volunteers said that, Film Coated tablets and Atenolol tablets, Actavis respectively are more cheaper than other brands. About 80 % to Atenolol tablets, Actavis and 70% to Film Coated tablets are more requested and desired to the patients or customers. Our survey represented about 80%Â and 70%Â of pharmacy purchases are belonged to Atenolol tablets, Actavis & Atenolol Normon respectively.Â Â Â Â Key wards : Atenolol, Î²-blockers, Hypertension, Tablets,Â Libyan market, brand.
Lifton, RP, Gharavi, AG and Geller DS. "Molecular mechanisms of human hypertension". Cell, 2001;104,(4):545â€“56.
Palatini, Pand Julius,S. "The role of cardiac autonomic function in hypertension and cardiovascular disease". Curr. Hypertens. Rep. 2009;11, (3) :199â€“205.
Sweetman, SC.(2007), Martindale: The Complete Drug Reference. (35th Edn), Royal Pharmaceutical Society, Pharmaceutical Press, London, UK.
United States Pharmacopeia and National Formulary (2006), USP 30â€“NF 25; United Pharmacopeial Convention, Inc Rockville, MD.
Sesardic, DPrior, C, Daas, Aand Buchheit KH. National Institute for Biological Standards and Control, Hertfordshire, Collaborative study for establishment of the European Pharmacopoeia BRP batch 1 for diphtheria toxin. Pharmeuropa Bio 2003: 5-21.
Vogelpoel, H Welink, J, Amidon,GL, Junginger, HE, Midha, KK, et al. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Verapamil hydrochloride, propranolol hydrochloride, and atenolol. J Pharm Sci, 2004; 93 :1945-1956.
Essential Medicines WHO Model List (EML) (15th-edn) World Health Organization (WHO).
WHO Expert Committee on Specifications for Pharmaceutical Preparations(2006).
Laurence, DR,Bennett, PN. Clinical pharmacology,1992 Seventh Edition , pp.393
Marketing authorization of pharmaceutical products with special reference to multisource (generic) products: a manual for drug regulatory authorities. Geneva, World Health Organization, (1998) (WHO/DMP/RGS/98.5)(http://apps.who.int/prequal/info_general/documents/WHO_DMP_RGS_98_5_R.pdf, accessed 12 March 2013
Babalola, CP. (2004) Bioavailability and bioequivalence (BA/BE) assessment. In Olaniyi AA et al, eds. Towards better quality assurance of drugs in the 3rd millennium. Biopharmaceutical methods in drug quality assurance, 1st ed. Ibadan, Nigeria, Omoadade Printing Press.
Dressman, JP et al.Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharmaceutical Research, 1998;15:11.
Samar, A.A . Shaimaa, AA. (2012), comparative study for evaluation of different brands of Metformin Hydrochloride 500 mg tablets marketed in Saudi Arabia. Life Science Journal, 2012;9:4260-4266.
Bundrick, W, Heron, SP . Ray,P, Schiff, WM, Tennenberg AM, et al. Levofloxacin versus Ciprofloxacin in treatment of chronic bacterial prostatitis : a randomized double-blind multicentre study. Urology, 2003;62 :537-541.
Rawan, MP,Sakina MS. (2012), Physicochemical comparison between five brands of atenolol available in Libyan market. Thesis.